Goldman Sachs Group Inc Milestone Pharmaceuticals Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,353,067 shares of MIST stock, worth $2.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,353,067
Previous 1,353,067
-0.0%
Holding current value
$2.44 Million
Previous $1.79 Million
15.12%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MIST
# of Institutions
45Shares Held
28.7MCall Options Held
200Put Options Held
0-
Black Rock Inc. New York, NY4.97MShares$8.95 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.86 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$5 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.79 Million1.79% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.06MShares$3.71 Million0.0% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $54M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...